[{"address1": "12230 El Camino Real", "address2": "Suite 230", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 434 1113", "fax": "858 408 3010", "website": "https://www.oncternal.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Dr. James B. Breitmeyer M.D., Ph.D.", "age": 69, "title": "President, CEO & Director", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 881355, "exercisedValue": 0, "unexercisedValue": 240953}, {"maxAge": 1, "name": "Mr. Richard G. Vincent CPA", "age": 59, "title": "CFO & Treasurer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 602843, "exercisedValue": 0, "unexercisedValue": 84897}, {"maxAge": 1, "name": "Dr. Rajesh  Krishnan Ph.D.", "age": 50, "title": "Chief Technical & Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chase C. Leavitt J.D.", "age": 41, "title": "General Counsel & Secretary", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Pablo  Urbaneja", "title": "Senior Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://phx.corporate-ir.net/phoenix.zhtml?c=148196&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.694, "open": 0.7, "dayLow": 0.5266, "dayHigh": 0.7, "regularMarketPreviousClose": 0.694, "regularMarketOpen": 0.7, "regularMarketDayLow": 0.5266, "regularMarketDayHigh": 0.7, "payoutRatio": 0.0, "forwardPE": -0.05137561, "volume": 644135, "regularMarketVolume": 644135, "averageVolume": 0, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 1558546, "fiftyTwoWeekLow": 0.5266, "fiftyTwoWeekHigh": 9.88, "priceToSalesTrailing12Months": 0.7212152, "fiftyDayAverage": 0.5266, "twoHundredDayAverage": 1.7806875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12828264, "profitMargins": 0.0, "floatShares": 2706683, "sharesOutstanding": 2959640, "sharesShort": 14209, "sharesShortPriorMonth": 16932, "sharesShortPreviousMonthDate": 1728950400, "dateShortInterest": 1731628800, "sharesPercentSharesOut": 0.0047999998, "heldPercentInsiders": 0.0923, "heldPercentInstitutions": 0.12073, "shortRatio": 0.09, "shortPercentOfFloat": 0.005, "impliedSharesOutstanding": 3187840, "bookValue": 3.091, "priceToBook": 0.17036557, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -34575000, "trailingEps": -11.69, "forwardEps": -10.25, "lastSplitFactor": "1:20", "lastSplitDate": 1704672000, "enterpriseToRevenue": -5.936, "52WeekChange": -0.9384093, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.5266, "targetHighPrice": 2.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.0, "targetMedianPrice": 2.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 14578000, "totalCashPerShare": 4.925, "totalDebt": 191000, "quickRatio": 2.259, "currentRatio": 2.394, "totalRevenue": 2161000, "debtToEquity": 2.088, "revenuePerShare": 0.73, "returnOnAssets": -0.76448995, "returnOnEquity": -1.49857, "grossProfits": -6515000, "freeCashflow": -17677376, "operatingCashflow": -26632000, "revenueGrowth": 1.76, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -17.57287, "financialCurrency": "USD", "symbol": "ONCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1075818600000, "regularMarketChange": -0.1674, "regularMarketDayRange": "0.5266 - 0.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 0, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.5266 - 9.88", "fiftyTwoWeekHighChange": -9.3534, "fiftyTwoWeekHighChangePercent": -0.9467004, "fiftyTwoWeekChangePercent": -93.840935, "dividendDate": 1560124800, "earningsTimestampStart": 1741172340, "earningsTimestampEnd": 1741608000, "earningsCallTimestampStart": 1723150800, "earningsCallTimestampEnd": 1723150800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.69, "epsForward": -10.25, "epsCurrentYear": -12.43, "priceEpsCurrentYear": -0.042365246, "fiftyDayAverageChange": 0.0, "fiftyDayAverageChangePercent": 0.0, "twoHundredDayAverageChange": -1.2540874, "twoHundredDayAverageChangePercent": -0.7042715, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1733173200, "exchange": "NCM", "messageBoardId": "finmb_344890993", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -24.121037, "regularMarketPrice": 0.5266, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "shortName": "Oncternal Therapeutics, Inc.", "longName": "Oncternal Therapeutics, Inc.", "displayName": "Oncternal Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]